Revolutionizing nanoparticle and RNA-LNP formulation with innovative microfluidic-based systems!

At InsideTX, we are revolutionizing nanoparticle manufacturing, to unlock the full potential of RNA-LNP therapeutics and nanomedicines.

At the convergence of microfluidics and biotechnology, we strive to provide laboratories, biotech, and pharma companies with the ultimate nanoparticle synthesis capabilities by solving three of the biggest challenges of the RNA-LNP revolution: Easing screeening, ensuring seamless scalability all along the development process and allowing for continuous production.

Leveraging our patented technology, our complementary team is developping the only end-to-end nanoparticle synthesis platform that accelerates your screening to production time while improving your probability of success.

In practices, our system allow for easy manufacturing of most lipidic or polymeric nanoparticles (liposomes, LNP, solid lipid nanoparticles, PLGAs...) using the same system all along your drug development process - from your screening stage at μL scale to your continuous production at 10s of L scale - while ensuring ultimate nanoparticle characteristics control at every step of the process.

Our TAMARA nanoparticle formulation system meets these challenges head-on, offering a comprehensive, all-in-one R&D platform that supports every phase of development, from initial screening to in-vivo studies. With zero dead volumes and reusable microfluidic chips, TAMARA is the ultimate solution for RNA-LNP or nanomedicine development.

But don’t just take our word for it—our users say it best: “I’m absolutely blown away by how user-friendly, efficient, and straightforward this system is!”